DNGR-1 antibody vaccine (Cancer Research UK)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameDNGR-1 antibody vaccine (Cancer Research UK)
Drug Alias NameClec9A antibody vaccine (Cancer Research UK)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Antigen > Tumor antigen +[4] 
Mechanisms of ActionC-type lectin domain family 7 member A modulators
TargetsC-type lectin domain family 7 member A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research TechnologyCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A